|Videos|May 4, 2017

Identifying Gaps in Antibiotic Stewardship

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, explains the importance of identifying gaps in antibiotic stewardship.

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, explains the importance of identifying gaps in antibiotic stewardship.

Interview Transcript (slightly modified for readability)

“There are so many gaps in antibiotic stewardship. It actually is a relatively new field, even though we’ve been thinking about improving how we use antibiotics for many decades. [However], there are a lot of areas where we don’t know very much about antibiotic prescribing.

One example is dentistry. We don’t know very much about how antibiotics are being prescribed in dentistry. We don’t know the frequency of appropriateness of antibiotic prescribing in dentistry and by dentists, and so we really like to better understand where the opportunities are for improvement.

There are some other areas in healthcare and some growing sectors in healthcare where we don’t really know how antibiotics are being prescribed and where the opportunities are for improvement, but we believe there are opportunities. For example, as you well know, retail clinics are becoming much more common, [and] urgent care clinics are becoming a very common source of healthcare in the community. We need to better understand how antibiotics are being used in those settings, and identify opportunities to improve antibiotic use there.

A couple of other areas we’re look at [include] dialysis patients, for example, and certain populations who are getting ambulatory surgery procedures. Those have been areas where we don’t know very much about how antibiotics are being used, but we need to learn more and identify opportunities to improve antibiotic [use].”


Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.